Catalyst Wire Dossier Catalyst Wire Dossier

Capsaicin 8% Transdermal Delivery System

capsaicin 8% patch · Astellas Pharma Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Capsaicin 8% Transdermal Delivery System, covering 2015-03-13 to 2015-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN) [Phase 3]

See pricing